Quick Answer
NEXGEL, INC. reported R&D Expense of $2.0 thousand for fiscal year 2025.
NEXGEL, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.0K | -97.4% |
| 2024 | $78.0K | -24.3% |
| 2023 | $103.0K | -71.9% |
| 2022 | $367.0K | +1083.9% |
| 2021 | $31.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.0K | — | +600.0% |
| March 31, 2025 | $1.0K | -50.0% | -98.7% |
| June 30, 2024 | $76.0K | +38.2% | +3700.0% |
| March 31, 2024 | $2.0K | -93.1% | -66.7% |
| September 30, 2023 | $6.0K | -96.9% | -89.1% |
| June 30, 2023 | $55.0K | -50.5% | +89.7% |
| March 31, 2023 | $29.0K | +20.8% | -85.0% |
| September 30, 2022 | $193.0K | — | +73.9% |
- NEXGEL, INC. showed a decrease of -97.4% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2025 period, NEXGEL, INC.’s r&d expense has declined by 93.5% (from $31.0 thousand to $2.0 thousand).
- The most recent figure is from NEXGEL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: